Lumentum’s Massive Backlog and Demand Justify Buying at Today’s Price

Lumentum (NASDAQ:LITE | LITE Price Prediction) trades at $995.41. It has an optical circuit switch (OCS) backlog that management put “well beyond $400 million”, and AI demand is running ahead of what the company can supply. Monday’s selloff in optical stocks pulled the shares lower after an extended run.

Lumentum makes lasers, transceivers and optical switches that move data inside and between hyperscale AI data centers. It reports two segments, Components and Systems. The stock has gained 565.34% over the past year. It fell 9.78% Monday alongside Ciena (NYSE:CIEN): Ciena, Lumentum and other optical stocks ranked among the market’s biggest losers.

Record Guidance and Sold-Out Lasers Fuel the Bull Case

Fiscal Q4 revenue came in at $1.006 billion, up 109.3% from a year earlier. Non-GAAP EPS of $3.23 beat the $2.97 consensus, making it the company’s fourth straight beat. Non-GAAP gross margin reached 50.4%, a level management had originally expected to hit only at a $2 billion quarterly run rate. Q1 guidance calls for $1.225 billion to $1.275 billion in revenue and a 39.5% to 40.5% non-GAAP operating margin.

Catalysts include a multi-hundred-million-dollar co-packaged optics (CPO) order due for delivery in 1H calendar 2027. Management calls Lumentum “really the only merchant supplier today of OCS”. It also estimates its pump-laser share at 70% to 80%. Analysts have raised the fiscal 2027 EPS consensus to $21.781 from $18.137 90 days ago.

A 170% Year-to-Date Surge Leaves Little Room for Error

At 33 times trailing sales and 115 times EV-to-EBITDA, the stock is priced for flawless execution. GAAP results muddy the picture: Lumentum reported a Q4 net loss of $7.16 billion, a gap with its non-GAAP profits that skeptics will dig into.

Supply is the other worry. Management admits it is “way behind our shipments” on high-power lasers. It also depends on limited indium phosphide substrate and faces new competition from Chinese fabs. CPO and near-packaged optics (NPO) volumes are not expected until 2027 and 2028, which leaves plenty of time for customer delays or cuts to hyperscaler spending (we covered seven suppliers riding that same data-center expansion, from power to optical infrastructure, in a free report you can grab here).

Delivery Proof Will Decide How Far the Backlog Story Runs

Turning the backlog into revenue depends on capacity Lumentum is still building. Its Greensboro fab is not expected to produce revenue until early 2028. The stock’s 8.82% weekly drop shows how fast sentiment can turn. If Q1 lands near the midpoint, the upside argument gets stronger. A margin slip would weaken it.

Wall Street Targets Point to Nearly 17% Upside

The consensus target of $1,161.96 means about 16.7% upside from $995.41. Price targets can shift quickly as estimates change. Lumentum is worth about $90.17 billion. The ratings summary:

• Strong Buy: 5
• Buy: 18
• Hold: 4
• Sell: 0

Year to date, the stock is up 170.06%, while the S&P 500 is up 14.1%. It trades at a forward P/E of 43 and about 28 times fiscal 2028 consensus EPS of $35.5659.

Milestones That Could Reprice Lumentum After the Selloff

At $995.41, Lumentum still has a premium valuation.

Several clear milestones mark the way forward. The first is the fiscal Q1 report, guided at $4.05 to $4.35 in EPS. Next comes CPO order delivery, followed by OCS leadership. Management expects to become the number one OCS supplier “sometime in early 27”.

The pullback from the $1,143 52-week high has cut some of the premium. If estimates hold, the multiple on 2028 earnings looks modest for a company growing revenue at triple digits.

The story falls apart if orders get canceled, supply limits cap shipments for longer, or gross margin falls back below 50%. Investors should track OCS revenue and pricing each quarter.

Demand is outpacing supply, which keeps capacity execution at the center of the story.

Contact [email protected] for any questions or corrections.